What Does Aurora Cannabis (ACB) Do? – Stock Outlook, Earnings, Market Cap, Related Stocks, and Headquarters Overview
Aurora Cannabis (ACB) is a Canada-based global medical cannabis production and distribution company. Its vertically integrated business structure, revenue growth trajectory, and earnings improvement prospects continue to draw steady attention across stock outlook, dividend, and related-stock market-cap discussions.
Subscribe🏢 What kind of company is Aurora Cannabis?
Aurora Cannabis (ACB) is a cannabis production and distribution company headquartered in Edmonton, Alberta, Canada, founded in 2013. Since its founding, it has built a vertically integrated business structure spanning cultivation and breeding through derivative product development, while expanding into the global medical cannabis market.
It operates a vertically integrated business covering medical and recreational cannabis cultivation, breeding and genetic research, derivative product development, and wholesale and retail distribution. It holds a leading position in the global medical cannabis distribution network spanning multiple countries.
How does Aurora Cannabis make money?| Business Segment | Revenue Share | Description |
|---|---|---|
| Global Medical Cannabis | Largest growth driver | Medical cannabis distribution and prescription channels across multiple countries |
| Recreational Cannabis | Core business | Domestic retail and wholesale distribution in Canada |
| Derivative Products | Expanding | High-value derivative product lines including oils and capsules |
| International Business | Diversification pillar | Overseas expansion channels including Europe and Latin America |
Recent annual revenue has shown a steady upward trajectory, and the year-over-year revenue change has maintained a moderate growth phase. The global medical cannabis segment has established itself as the core growth driver of revenue, with continued expansion of country-specific prescription channels, while recreational cannabis and derivative products support revenue diversification. Operating margin trends vary depending on cost structure and the progress of production efficiency improvements.
📐 Aurora Cannabis market cap and company scale
Market capitalization stands at $242.5M, and the company employs 1,028 people people.
Within the global cannabis industry, it belongs to the small-to-mid-cap segment frequently compared with CRON and TLRY, and among Canadian-based cannabis companies, it leans more heavily toward medical channels. Its market capitalization places it in the micro-cap range, and as a growth-stage company, it is focused on capital allocation efficiency during the profitability improvement phase.
📈 Aurora Cannabis outlook and stock price trends
1-Year Price Performance
Analyst Consensus
52-Week Price RangeThe expansion of the global medical cannabis market and the easing of regulations across various countries serve as medium- to long-term growth drivers. Expansion into new markets such as Europe and Latin America, along with the broadening of prescription channels, holds potential to support revenue growth, while the widening of derivative product lines can also contribute to margin improvement. In the short term, pricing pressure stemming from industry-wide supply oversupply and business uncertainty arising from changes in regulatory environments across countries may act as volatility factors.
⚔️ Aurora Cannabis key strengths and risks
Its global medical cannabis distribution network and vertically integrated production structure are strengths, while industry-wide oversupply and regulatory volatility are core risks. Key Strengths: Vertically Integrated Structure Operates all stages in-house, from cultivation through derivative products to distribution, providing advantages in cost and quality control. Global Medical Channels Secures medical cannabis prescription channels across multiple countries, establishing a stable revenue base. Derivative Product Diversification Diversifies revenue through high-value derivative product lines including oils and capsules. Key Risks: Industry Supply Oversupply A growing number of cannabis cultivators has intensified price competition, leading to continued margin pressure. Regulatory Volatility Changes in cannabis-related regulatory environments across countries can significantly affect the pace of business expansion. Profitability Variability Production efficiency improvements are underway, but additional time is required before a stable turnaround to profitability.🔄 Aurora Cannabis competitors and related stocks (beneficiaries)
Direct competitors include other global cannabis production and distribution companies such as CRON, TLRY, and OGI. Related stocks include GRWG, which supplies cannabis cultivation equipment and supplies, and SNDL, which runs adjacent beverage and distribution businesses alongside cannabis.
Competitors| Ticker | Company | Price | Change | Market Cap | P/E | PBR | ROE | Dividend Yield |
|---|---|---|---|---|---|---|---|---|
 CRON | Cronos Group Inc | $3.14 | -0.6% | $1.2B | 17.1 | 1.1 | 6.51% | - |
 TLRY | Tilray Brands Inc | $4.02 | -2.9% | $547.5M | - | 0.3 | -7.77% | - |
 OGI | Organigram Global Inc | $1.05 | -1.9% | $148.1M | 2.3 | 0.4 | 19.95% | - |
Related stocks (beneficiaries)| Ticker | Company | Price | Change | Market Cap | P/E | PBR | ROE | Dividend Yield |
|---|---|---|---|---|---|---|---|---|
 GRWG | GrowGeneration Corp | $1.53 | -2.5% | $90.2M | - | 1.0 | -17.07% | - |
 SNDL | SNDL Inc | $1.34 | +0.0% | $332.7M | - | 0.4 | -2.05% | - |
✅ Aurora Cannabis investor checklist
Key points to review when investing in Aurora Cannabis. The pace of expansion in global medical cannabis channels, whether industry-wide supply oversupply eases, and changes in regulatory environments across countries are the key short- and medium-term variables.
| Checkpoint | What to Verify | Current Status |
|---|---|---|
| 📈 Revenue Growth | Revenue trends in global medical cannabis channels | Growth trajectory maintained |
| 💵 Profitability Improvement | Progress in operating margin and cost efficiency | Improvement needs monitoring |
| 🌍 Regulatory Environment | Cannabis-related regulatory changes in major countries | Changes need monitoring |
| ⚔️ Industry Competition | Whether supply oversupply and price competition ease | Competition continues |
Industry-wide price competition stemming from supply oversupply may translate into margin pressure, and changes in regulatory environments across countries can have a significant impact on the pace of business expansion. Additional time may be needed before a stable turnaround to profitability, which is also a risk factor.
It is a leading Canadian cannabis company equipped with global medical cannabis channels and a vertically integrated production structure. Industry supply oversupply and regulatory volatility are key variables to monitor, and a dollar-cost averaging approach with a long-term perspective is warranted.
Subscribe Today's 5 AI picks, all free